News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,316 Results
Type
Article (29)
Press Release (3287)
Section
Business (1335)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (268)
News (2105)
Policy (116)
Tag
Academia (3)
Allergies (2)
Alliances (44)
Alzheimer's disease (31)
Antibody-drug conjugate (ADC) (3)
Approvals (112)
Artificial intelligence (1)
Autoimmune disease (2)
Bankruptcy (1)
Best Places to Work (297)
Breast cancer (11)
Cancer (97)
Cardiovascular disease (10)
Career advice (1)
Cervical cancer (1)
Clinical research (691)
Collaboration (4)
Compensation (4)
COVID-19 (4)
C-suite (1)
Data (141)
Depression (1)
Diabetes (1)
Diagnostics (22)
Drug discovery (1)
Drug pricing (1)
Duchenne muscular dystrophy (1)
Earnings (1547)
Events (354)
FDA (160)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (5)
Generative AI (1)
Gene therapy (4)
GLP-1 (8)
Government (9)
Guidances (28)
Healthcare (85)
IgA nephropathy (3)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (161)
IRA (1)
Job creations (1)
Job search strategy (1)
Kidney cancer (2)
Layoffs (2)
Legal (1)
Lung cancer (40)
Lymphoma (10)
Manufacturing (1)
MASH (5)
Medical device (57)
Medtech (57)
Mergers & acquisitions (27)
Metabolic disorders (7)
Multiple sclerosis (7)
NASH (1)
Neuroscience (48)
NextGen: Class of 2025 (9)
Non-profit (4)
Obesity (1)
Opinion (1)
Ovarian cancer (2)
Pancreatic cancer (1)
Parkinson's disease (2)
Patient recruitment (1)
Peanut (1)
People (9)
Phase I (101)
Phase II (207)
Phase III (415)
Pipeline (124)
Policy (1)
Postmarket research (27)
Preclinical (13)
Prostate cancer (3)
Radiopharmaceuticals (6)
Rare diseases (9)
Regulatory (156)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Rett syndrome (2)
Schizophrenia (4)
Sponsored (1)
Startups (3)
Vaccines (5)
Date
Last 7 days (2)
Last 30 days (54)
Last 365 days (430)
2025 (399)
2024 (419)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (356)
Australia (14)
California (98)
Canada (26)
China (18)
Connecticut (5)
Delaware (20)
Europe (664)
Florida (13)
Georgia (2)
Illinois (9)
Indiana (19)
Japan (17)
Kansas (1)
Maryland (20)
Massachusetts (75)
Minnesota (9)
New Jersey (80)
New York (40)
North Carolina (13)
Northern California (67)
Ohio (4)
Pennsylvania (32)
South America (5)
Southern California (25)
Texas (16)
United States (463)
Utah (8)
Virginia (1)
Washington State (6)
3,316 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Almirall’s 2025 9M Results
November 10, 2025
·
7 min read
Press Releases
Maze Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights
November 6, 2025
·
10 min read
Press Releases
BiomX Reports Third Quarter 2025 Financial Results and Provides Program Updates
November 13, 2025
·
13 min read
Press Releases
New Phase 3 Data Show Takeda’s Dengue Vaccine Delivers 7 Years of Sustained Protection Against Infection and Hospitalization
November 4, 2025
·
16 min read
Press Releases
Tenaya Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
·
13 min read
Press Releases
Celldex Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 10, 2025
·
13 min read
Press Releases
Supernus Announces Third Quarter 2025 Financial Results
November 4, 2025
·
19 min read
Press Releases
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
November 20, 2025
·
17 min read
Press Releases
Baxdrostat demonstrated a statistically significant and highly clinically meaningful placebo-adjusted reduction of 14.0 mmHg in 24-hour ambulatory systolic blood pressure in patients with resistant hypertension in the Bax24 Phase III trial
November 10, 2025
·
15 min read
Press Releases
AMGEN REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS
November 4, 2025
·
46 min read
1 of 332
Next
